Volume 11, Number 10—October 2005
Research
Vancomycin and Home Health Care
Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*
Table 4
Infection diagnoses in patients referred for home infusions of vancomycin
| Diagnosis* | Use per guidelines, no. (%), N = 180 | Use outside guidelines, no. (%), N = 116 | p value† |
|---|---|---|---|
| Skin or soft tissue infection | 89 (49.4) | 51 (44.0) | 0.356 |
| Osteomyelitis or septic arthritis | 30 (16.7) | 25 (21.6) | 0.294 |
| Postoperative wound infection | 38 (21.1) | 19 (16.4) | 0.310 |
| Orthopedic device-related infection | 5 (2.8) | 7 (6.0) | 0.227 |
| Central nervous system infection‡ | 3 (1.7) | 6 (5.2) | 0.161 |
| Urinary tract infection | 36 (20.0) | 13 (11.2) | 0.042 |
| Pneumonia | 9 (5.0) | 1 (0.9) | 0.095 |
| Bloodstream infection | 61 (33.9) | 16 (13.8) | <0.001 |
| Vascular device infection | 21 (11.7) | 10 (8.6) | 0.398 |
| Infective endocarditis | 8 (4.4) | 5 (4.3) | 0.956 |
*Some patients had >1 diagnosis.
†Values <0.05 were considered significant.
‡Includes shunt infections.
1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA
